دراسة العلاقه بين نسبة قبط اليود المشع وكل من الهرمون المحفز للدرقيه والجرعه المستخدمه في معالجة فرط نشاط الغدة الدرقية بأستخدام اليود المشع I131

Abstract

The study was done in ( Atomic Radiation and Nuclear Medicine ) hospital in Baghdad, we reviewed and analysed medical records of patients with graves goiter type diffuse toxic goiter and toxic nodular goiter . We selected 150 patient include their medical records on enough information about result of treatment by 131I for stage from 3- 18 months. Iodine - 131 was delivered as a single dose (200 µci/gm thyroid tissue corrected to 100% 24 h I-131 uptake) . methimazole treatment was discontinued for 1 week ,befor I-131 therapy. The result of treatment showed that the relation between radiation dose treatment of Iodine radioactive and both Iodine radioactive uptake rate, and is opposite relation for the diffuse toxic goiter group and toxic nodular goiter group.